Drug Approval | September 18, 2021
Zydus Cadila receives final nod for anti-depressant
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
The hospital through its network performs more than 10,000 joint replacement surgeries annually
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
BD worked with JCI to create a Gold Standard benchmarked safety program called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME)
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Lenalidomide is used to treat cancer and also some anaemia disorders
The group has a total of 320 ANDA approvals
Subscribe To Our Newsletter & Stay Updated
